Unity Biotechnology, Inc. (UBX) Financials
UBX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 69.3 million | 33.1 million |
2023-06-30 | 101.0 million | 51.6 million |
2023-03-31 | 114.3 million | 55.6 million |
2022-12-31 | 124.4 million | 57.5 million |
UBX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.1 million | 2.1 million |
2023-06-30 | -11.1 million | 2.4 million |
2023-03-31 | -11.3 million | 2.3 million |
2022-12-31 | -10.4 million | 2.3 million |
UBX Net Income
No data available :(
UBX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 45.9 million | - | 24.4 million |
2023-06-30 | 69.1 million | 4.1 million | 25.3 million |
2023-03-31 | 83.4 million | 7.6 million | 26.2 million |
2022-12-31 | 94.8 million | 10.9 million | 30.1 million |
UBX Shares Outstanding
UBX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 11000 | 4.9 million | 4.4 million | - |
2023-06-30 | - | 6.5 million | 5.4 million | - |
2023-03-31 | - | 5.8 million | 4.8 million | - |
2022-12-31 | 37000 | 8.6 million | 5.3 million | - |
UBX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 308000 |
2023-06-30 | - | 314000 |
2023-03-31 | - | 329000 |
2022-12-31 | -236000 | 409000 |
UBX
Price: $1.63
52 week price:
Earnings Per Share: -3.20 USD
P/E Ratio: -0.53
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 71934
Market Capitalization: 25.5 million